2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Blood Banking, Clinical Procedures, Treatment Considerations, Combination Therapy, Drug Development, Drug-Drug Interactions, Supportive Care, Therapy Sequence, Biological Therapies, Transfusion, Vaccines, Non-Biological Therapies, Opioids, Women’s Health, Adverse Events, Biological Processes, Hematopoiesis, Metabolism, Clinical Practice (Health Services and Quality), Patient Safety, Quality Improvement, Quality of Care, Systems-Based Hematology, Diseases, Bleeding and Clotting, Thromboembolism, Thrombotic Disorders, Genetic Disorders, Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Trait, Thalassemia, Immunology, Immunodeficiency, Infectious Diseases, Bacterial, Research, Clinical Research, Clinical Trials, Epidemiology, Health Outcomes Research, Health Disparities Research, Patient-Reported Outcomes, Real-World Evidence, Registries, Study Population, Human, Adult, Pediatric, Young Adult
PAPER

4689 Pica in paediatric sickle cell disease: Clinician under-recognition and absence of a distinct biochemical phenotype in an age-matched case-control analysis

Fahd Umar, Michelle Asumah2, Maria Goridari3, John Brewin, MD, PhD, MRCP, FRCPath4, Subarna Chakravorty, MBBS, MRCPCH, FRCP, FRCPath, PhD5
1 King's College London, London, United Kingdom
2 King's College London, London, United Kingdom
3 South London and Maudsley NHS Trust, London, United Kingdom
4 King's College London, London, United Kingdom
5 King's College Hospital, London, United Kingdom

Background. Pica, the persistent ingestion of non-food substances, has been reported in up to one third of paediatric sickle cell disease (SCD) cohorts. Historically, pica has been attributed to iron or zinc deficiency and can lead to gastrointestinal complications and environmental lead exposure. A 10-year-old girl with HbSS and pica in our centre for concrete presented with abdominal pain and constipation and had severe lead poisoning (serum lead 4.124 mol/l, normal 0.000-0.239), needing multiple courses of lead chelation with dimercaptosuccinic acid, intense psychological therapy and substantial structural change in their family home. Pica in children with SCD is often overlooked, and clinicians underestimate the behaviour relative to caregiver report. However, the magnitude of this documentation gap and the biochemical phenotype of clinician-detected cases remain poorly characterised. Whether the classical iron or zinc deficiency model holds against age-matched controls from the same SCD population, and the effect of psychological intervention, is not known.

Methods. We conducted a single-centre mixed-methods study comprising: (1) a retrospective electronic medical records (EMR) based audit of 405 paediatric SCD patients (261 HbSS, 97 HbSC, 47 other genotypes) to estimate clinician-recorded pica prevalence by genotype with Wilson 95% confidence intervals (CI); (2) an age-matched case-control analysis of 20 HbSS pica-positive cases against 20 HbSS controls without pica from a separate comparator dataset, comparing haemoglobin, MCV, ferritin, and zinc using Mann-Whitney U tests with Benjamini-Hochberg adjustment for multiple testing, and multivariate logistic regression (ferritin + age; zinc + age); and (3) an anonymous caregiver questionnaire (n = 27) capturing parent-reported pica behaviour. Age matching used age at biochemistry sampling in an outpatient setting (cases median 7.5 years, controls 7.4 years; Mann-Whitney p = 0.98).

Results. Clinician-recorded pica prevalence was 18% (95% CI 13.8 to 23.1) in HbSS and 8.2% (95% CI 4.2 to 15.4) in HbSC. In the caregiver questionnaire, 77.8% of respondents (95% CI 59.2 to 89.4) reported pica in their child, approximately four-fold the EMR-recorded HbSS rate; only 52.4% had discussed it with a clinician, and 40.0% had received a formal diagnosis. Parent-reported median age of onset was 4.5 years, compared with 7.5 years in EMR-audited cases. In the age-matched case-control comparison, no biochemistry variable distinguished cases from controls: haemoglobin Hodges-Lehmann difference -0.7 g/L (95% CI -7.8 to +4.7), p = 0.71; MCV +1.6 fL (95% CI -5.2 to +8.0), p = 0.68; ferritin +26 ng/mL (95% CI -19 to +77), p = 0.18 (BH-adjusted p = 0.64); zinc +0.4 µmol/L (95% CI -0.6 to +1.2), p = 0.32. Multivariate logistic regression yielded area under receiver operating characteristic of 0.63 for ferritin + age and 0.52 for zinc + age, with no significant independent predictor identified. Materials consumed were predominantly cellulose (paper, tissue, sponge), with a clinically important minority reporting paint, chalk, and soil. Documented lead screening had been performed in only 2 of 20 audited cases. Constipation and abdominal pain were each documented in 35% of cases.

Conclusions. In our cohort, pica is recorded in 18% of HbSS patients by clinicians but reported in approximately 78% of caregivers, an approximately four-fold documentation gap, with fewer than half of families having raised it with a clinician. In an age-matched case-control comparison, pica in HbSS was not characterised by a distinct biochemical phenotype, challenging the classical iron and zinc deficiency model in this population. Approximately half of the children with PICA (49%) were referred to psychology (47% of the HbSS cohort). Parent testimonies indicate good response to Integrated psychological intervention. Further research is needed to define the developmental, psychosocial, and environmental determinants of pica in SCD, to quantify lead exposure given the patient-reported materials consumed, and to evaluate routine screening at every clinic encounter.

 

Fahd Umar: No relevant conflicts of interest to declare.